Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ENOCHIAN BIOSCIENCES, INC.

(ENOB)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société ENOCHIAN BIOSCIENCES, INC.
10/18ENOCHIAN BIOSCIENCES ANNOUNCES THE S : The Second Pre-IND in 1 month
PU
10/18ENOCHIAN BIOSCIENCES ANNOUNCES THE S : The Second Pre-IND in 1 month
AQ
10/15ENOCHIAN BIOSCIENCES : Scientific Advisory Board Member Resigns Due to Conflict with Respo..
PU
10/15ENOCHIAN BIOSCIENCES : Scientific Advisory Board Member Resigns Due to Conflict with Respo..
AQ
10/12ENOCHIAN BIOSCIENCES : Fireside Chat with Enochian BioSciences' CEO, Dr. Mark Dybul at H.C..
PU
10/12ENOCHIAN BIOSCIENCES : Fireside Chat with Enochian BioSciences' CEO, Dr. Mark Dybul at H.C..
AQ
09/27ENOCHIAN BIOSCIENCES : Announces Its Successful Completion of FDA Pre-IND for a Potential ..
PU
09/27ENOCHIAN BIOSCIENCES : Announces Its Successful Completion of FDA Pre-IND for a Potential ..
AQ
09/24ENOCHIAN BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Res..
AQ
09/13ENOCHIAN BIOSCIENCES INC : Regulation FD Disclosure, Financial Statements and Exhibits (fo..
AQ
09/13ENOCHIAN BIOSCIENCES : Slide Presentation Here
PU
09/13ENOCHIAN BIOSCIENCES : to Present to Investors at the H.C. Wainwright 23rd Annual Investme..
AQ
08/30ENOCHIAN BIOSCIENCES : Distinguished Scientific and Public Health Leaders to Join Enochian..
PU
08/30ENOCHIAN BIOSCIENCES INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/30ENOCHIAN BIOSCIENCES : Distinguished Scientific and Public Health Leaders to Join Enochian..
AQ
08/23ENOCHIAN BIOSCIENCES : Distinguished Scientific and Clinical Leader to Join Enochian BioSc..
PU
08/16ENOCHIAN BIOSCIENCES : Entry into a Material Definitive Agreement, Financial Statements an..
AQ
07/23ENOCHIAN BIOSCIENCES : Names The Hon. Dr. Mark Dybul as Chief Executive Officer (Form 8-K)
PU
07/23ENOCHIAN BIOSCIENCES INC : Entry into a Material Definitive Agreement, Regulation FD Discl..
AQ
07/20ENOCHIAN BIOSCIENCES : Names The Hon. Dr. Mark Dybul as Chief Executive Officer
AQ
07/12ENOCHIAN BIOSCIENCES : Announces FDA Acceptance of Pre-IND Request For Potential Cure for ..
PU
07/12ENOCHIAN BIOSCIENCES : Announces FDA Acceptance of Pre-IND Request For Potential Cure for ..
AQ
06/30Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice wi..
GL
06/21ENOCHIAN BIOSCIENCES : Announces Acquisition of Exclusive License for Potential Pan-Corona..
AQ
06/16ENOCHIAN BIOSCIENCES : Registered Direct Offering (Form 8-K)
PU
06/16ENOCHIAN BIOSCIENCES INC : Entry into a Material Definitive Agreement, Financial Statement..
AQ
06/14Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Mar..
GL
06/14ENOCHIAN BIOSCIENCES : Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure
PU
06/14ENOCHIAN BIOSCIENCES : Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure
AQ
05/27ENOCHIAN BIOSCIENCES INC : Change in Directors or Principal Officers (form 8-K)
AQ
05/17ENOCHIAN BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Res..
AQ
05/12ENOCHIAN BIOSCIENCES : announces Scientific Presentation of a Person with HIV Exhibiting C..
AQ
04/22ENOCHIAN BIOSCIENCES INC : Entry into a Material Definitive Agreement, Financial Statement..
AQ
04/16ENOCHIAN BIOSCIENCES INC : Change in Directors or Principal Officers (form 8-K)
AQ
03/24Seraph Research Institute and Enochian BioSciences Publish a Case Report of Complete Re..
GL
03/24ENOCHIAN BIOSCIENCES INC : Unregistered Sale of Equity Securities, Regulation FD Disclosur..
AQ
03/10ENOCHIAN BIOSCIENCES INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
03/09ENOCHIAN BIOSCIENCES INC : Regulation FD Disclosure (form 8-K)
AQ
02/22ENOCHIAN BIOSCIENCES : to Present to Investors at the H.C. Wainwright Global Life Sciences..
PU
02/16ENOCHIAN BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Res..
AQ
2020ENOCHIAN BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Res..
AQ
2020ENOCHIAN BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Res..
AQ
2020ENOCHIAN BIOSCIENCES INC : Regulation FD Disclosure (form 8-K)
AQ
2020ENOCHIAN BIOSCIENCES : to Present to Investors at 22nd Annual H.C. Wainwright Global Inves..
AQ
2020Enochian BioSciences to Present to Investors at 22nd Annual H.C. Wainwright Global Inve..
GL
2020Distinguished Scientific Leaders to Join Enochian BioSciences Hepatitis B Scientific Ad..
GL
2020ENOCHIAN BIOSCIENCES INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020ENOCHIAN BIOSCIENCES INC : Entry into a Material Definitive Agreement, Financial Statement..
AQ
2020ENOCHIAN BIOSCIENCES INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2020ENOCHIAN BIOSCIENCES INC : Change in Directors or Principal Officers (form 8-K)
AQ
2020ENOCHIAN BIOSCIENCES INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020Enochian BioSciences Announces Its Successful Completion of FDA INTERACT Meeting for a ..
GL
2020ENOCHIAN BIOSCIENCES INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020Enochian Biosciences Announces Three Scientific Presentations on Potential HIV and HBV ..
GL
2020ENOCHIAN BIOSCIENCES : Fiscal 3Q Earnings Snapshot
AQ
2020ENOCHIAN BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Res..
AQ
2020ENOCHIAN BIOSCIENCES INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020ENOCHIAN BIOSCIENCES : Announces Scientific Presentations at the American Society of Cell ..
AQ
2020ENOCHIAN BIOSCIENCES INC : Creation of a Direct Financial Obligation or an Obligation unde..
AQ
2020ENOCHIAN BIOSCIENCES INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020Enochian Biosciences Announces FDA INTERACT Meeting for a Potential Cure for HIV
GL
2020ENOCHIAN BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Res..
AQ
2020ENOCHIAN BIOSCIENCES : 10-q
PU
2020ENOCHIAN BIOSCIENCES INC : Entry into a Material Definitive Agreement, Other Events, Finan..
AQ
2020Enochian Biosciences Acquires an Exclusive License for a Novel Hepatitis B Virus Potent..
GL
2020ENOCHIAN BIOSCIENCES : Form 3
PU
2020ENOCHIAN BIOSCIENCES : Form 4
PU
2020Enochian Biosciences, a company focused on gene-modified cellular therapy in infectious..
AQ
2020Enochian Biosciences, a company focused on gene-modified cellular therapy in infectious..
GL
2020ENOCHIAN BIOSCIENCES INC : Change in Directors or Principal Officers (form 8-K)
AQ
2019ENOCHIAN BIOSCIENCES INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2019Enochian Biosciences Announces Scientific Presentation of a Novel Approach to Potential..
GL
2019ENOCHIAN BIOSCIENCES : Form 8-k
PU
2019ENOCHIAN BIOSCIENCES INC : Change in Directors or Principal Officers (form 8-K)
AQ
2019ENOCHIAN BIOSCIENCES INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
1  2Next